Hollandbio welcomes CiNTL Pharma as new member
Hollandbio connects, represents and supports the Dutch biotech sector. With more than 290 members – from start-ups and scale-ups to established companies active in health, food and the biobased economy – we work together to strengthen the Dutch life sciences ecosystem. Today, we are pleased to welcome CiNTL Pharma as our newest member.
Based in Utrecht, CiNTL Pharma is a data-driven contract research organization (CRO) that is rethinking how clinical research is conducted. By combining scientific expertise, advanced data capabilities and execution within a single integrated platform, the company supports biopharmaceutical innovators across a broad range of therapeutic areas and development phases.
As Europe’s first fully agentic, data-driven CRO, CiNTL Pharma brings innovative approaches to clinical development that can help accelerate the path from scientific discovery to patient impact. Their expertise in clinical research and data management further strengthens the Dutch and European life sciences ecosystem and contributes to a more efficient, innovation-driven clinical development landscape.
Yolanda Cabrera-Sybesma, CEO of CiNTL Pharma: “By joining hollandbio, we strengthen our commitment to the Dutch biotech sector and unlock unprecedented opportunities for sponsors seeking innovation-driven partners. Together, we’re redefining how clinical trials should be managed.”
We warmly welcome Yolanda, Agnes, Shuling and the entire CiNTL team to the hollandbio community!
For general inquiries, please contact us at info@cintlpharma.com
Direct contacts:
- Yolanda Cabrera-Sybesma, Co-Founder & CEO: yc.sybesma@cintlpharma.com
- Agnes Versteegen, Co-Founder & CPMO: a.versteegen@cintlpharma.com
- Shuling Ferradas Fernandez, CRA: sf.ferradas@cintlpharma.com
